ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 574 • 2016 ACR/ARHP Annual Meeting

    Anti-CCP3.1 and Anti-CCP3-IgA Antibodies Are Associated with Increasing Age in Subjects without Rheumatoid Arthritis

    Heather Berens-Norman1,2, Sonia Khatter3, Wendy M. Kohrt4, Catherine Jankowski5, Michael Weisman6, Michael Mahler7, James R. O'Dell8, Ted R Mikuls8, Richard M. Keating9, Jane H. Buckner10, Peter K. Gregersen11, Jill M. Norris12, V. Michael Holers13, Kevin D. Deane13 and M. Kristen Demoruelle13, 1Division of Rheumatology, University of Colorado Denver, Aurora, CO, 2Division of Rheumatology, University of Colorado School of Medicine, Denver, CO, 3University of Colorado School of Medicine, Aurora, CO, 4Geriatric Medicine Division, University of Colorado Denver, Aurora, CO, 5University of Colorado College of Nursing, Aurora, CO, 6Cedars-Sinai Medical Center, Los Angeles, CA, 7Research and Development, Inova Diagnostics, San Diego, CA, 8Veteran Affairs Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, 9Division of Rheumatology, Scripps Health, La Jolla, CA, 10Benaroya Research Institute at Virginia Mason, Seattle, WA, 11The Feinstein Institute for Medical Research, Manhasset, NY, 12Epidemiology, Colorado School of Public Health, Aurora, CO, 13Rheumatology Division, University of Colorado Denver, Aurora, CO

    Background/Purpose: Serum anti-CCP antibodies are specific for RA in the setting of inflammatory arthritis (IA) and can be elevated for several years prior to the…
  • Abstract Number: 575 • 2016 ACR/ARHP Annual Meeting

    Differences in Histological Scores and Histoclinical Correlations in ACPA- Versus ACPA+ Rheumatoid Arthritis Patients

    Fadil Pirbuccus1, Christine Galant1, Adrien Nzeusseu Toukap2, Frédéric A. Houssiau1, Patrick Durez2 and Bernard R. Lauwerys1, 1Pôle de pathologies rhumatismales inflammatoires et systémiques, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium, 2Pôle de Maladies Rhumatismales, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium

    Background/Purpose:  Differences in the pathogenesis of ACPA- versus ACPA+ rheumatoid arthritis are still poorly understood. In this study, we compared patterns of synovial changes in…
  • Abstract Number: 576 • 2016 ACR/ARHP Annual Meeting

    Anti-CCP3.1 and Anti-CCP3-IgA Are Elevated in RA-Free Subjects with Idiopathic Pulmonary Fibrosis

    Scott Matson1, Joshua J. Solomon2, Jeffrey J. Swigris2, Jonathan Chung3, Michael Mahler4, Kevin D. Deane5 and M. Kristen Demoruelle5, 1Medicine, University of Colorado Denver, Aurora, CO, 2Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, CO, 3Radiology, University of Chicago Medical Center, Chicago, IL, 4Research and Development, Inova Diagnostics, San Diego, CA, 5Rheumatology Division, University of Colorado Denver, Aurora, CO

    Background/Purpose: In RA-associated interstitial lung disease (RA-ILD), higher levels of anti-CCP antibodies have been associated with the presence and severity of ILD suggesting a potential…
  • Abstract Number: 577 • 2016 ACR/ARHP Annual Meeting

    TCZ Modulates the Production of Ccfdna Derived from RA Synovial Cells

    Naonori Hashimoto1, Kohsuke Yoshida1, Teppei Hashimoto2, Ayako Nakai1, Kenta Kaneshiro1, Kohjin Suzuki1, Yoshiko Kawasaki2, Nao Shibanuma3, Natsuko Nakagawa4, Yoshitada Sakai5 and Akira Hashiramoto6, 1Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan, 2Department of Rheumatology, Kobe Kaisei Hospital, Kobe, Japan, 3Departmant of Orthopaedic Surgery, Kobe Kaisei Hospital, Kobe, Japan, 4Department of Orthopaedic Surgery, Konan-Kakogawa Hospital, Kakogawa, Japan, 5Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 6Department of Biophysics, Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan

    Background/Purpose:   DNA is fragmented and released into blood circulation as a circulating cell-free DNA (ccfDNA) because of damage or death of cells. Although the…
  • Abstract Number: 578 • 2016 ACR/ARHP Annual Meeting

    Do Specific Anti-Citrullinated Antibodies Predict Different Phenotype of Rheumatoid Arthritis?

    Mikael Brink1, Monika Hansson2, Linda Mathsson-Alm3,4, Johan Rönnelid5, Karl Skriner6, Guy Serre7, Lars Klareskog2 and Solbritt Rantapää-Dahlqvist1, 1Rheumatology, Umeå University, Umeå, Sweden, 2Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 3ThermoFisher Scientific, Uppsala, Sweden, Uppsala, Sweden, 4Thermo Fisher Scientific, Uppsala, Sweden, 5Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, 6Humboldt University of Berlin, Berlin, Germany, 7Unité Différenciation Épidermique et Autoimmunité Rhumatoïde, Unité Mixte de Recherche, INSERM, Toulouse, France

    Background/Purpose:  Antibodies against cyclic citrullinated peptides (anti-CCP) have been suggested to identify a more severe phenotype of rheumatoid arthritis. In this study we have analysed…
  • Abstract Number: 579 • 2016 ACR/ARHP Annual Meeting

    MRI-Detected Osteitis Is Not Associated with the Presence or Level of ACPA Alone, but with the Combined Presence of ACPA and RF

    Debbie M. Boeters1, Wouter P. Nieuwenhuis1, Marije K. Verheul1, Elize C. Newsum1, Monique Reijnierse2, René E.M. Toes1, Leendert A. Trouw1 and Annette H.M. van der Helm-van Mil1, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Radiology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Within rheumatoid arthritis (RA) bone marrow edema (BME, osteitis) and anti-citrullinated protein antibodies (ACPAs) are associated with radiographic progression. ACPA has been associated with…
  • Abstract Number: 580 • 2016 ACR/ARHP Annual Meeting

    Preferential Distribution of M1 Monocytes in Anti-Cyclic Citrullinated Peptide Antibody Positive Patients with Rheumatoid Arthritis

    Shoichi Fukui1, Naoki Iwamoto2, Toshimasa Shimizu2, Masataka Umeda2, Ayako Nishino3, Yoshiro Horai2, Tomohiro Koga4, Shin-ya Kawashiri5, Kunihiro Ichinose6, Yasuko Hirai2, Mami Tamai6, Hideki Nakamura5, Tomoki Origuchi7 and Atsushi Kawakami4, 1Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 2Department of Immunology and Rheumatology, Unit of Translational Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan, 3Department of Immunology and Rheumatology, Unit of Translational Medicine, Graduate School of Biomedical Sciences, Nagasaki Universit, Nagasaki, Japan, 4Unit of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 5Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 6Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 7Department of Rehabilitation Sciences, Nagasaki University, Nagasaki, Japan

    Background/Purpose: In rheumatoid arthritis (RA), bone erosions are caused mainly by osteoclasts. Osteoclasts are derived from monocytes and macrophages (MoMa). MoMa consists of different subtypes…
  • Abstract Number: 581 • 2016 ACR/ARHP Annual Meeting

    Cell-Mediated Neutrophil Lysis-a Mechanism Promoting Hypercitrullination in Rheumatoid Arthritis?

    Tal Gazitt1, Christian Lood1, Xizhang Sun2, David Feith3, Jeffrey Ledbetter2, Gordon Starkebaum1, Thomas Loughran Jr.4 and Keith B. Elkon1, 1Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, 2University of Washington, Seattle, WA, 3Hematology and Oncology, University of Virginia, Charlottesville, VA, 4Hematology Oncology, University of Virginia, Charlottesville, VA

    BACKGROUND/PURPOSE:Protein citrullination, the post-translational conversion of arginine to citrulline, mediated by peptidylarginine deiminase (PAD) enzymes, is considered a likely mechanism for the stimulation of anti-citrullinated…
  • Abstract Number: 582 • 2016 ACR/ARHP Annual Meeting

    ACPA Induce Pathogenic Cytokines Expression in PBMC of ACPA+-RA Patients and Inhibition of Its Effect By Cit-ME a Synthetic Citrullinated Peptide

    Smadar Gertel1, Gidi Karmon2, Eszter Szarka3, , Esther Houri-Levi4, Edna mozes5, Yehuda Shoenfeld4 and Howard Amital6,7, 1Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, 2Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel, 3Department of Immunology,, Eötvös Loránd University, Budapest,, Budapest, Hungary, 4Zabludowicz Center For Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel, Ramat-Gan, Israel, 5Department of Immunology,, The Weizmann Institute of Science, Rehovot, Israel., Rehovot, Israel, 6Department of Medicine B, Center for Autoimmune Diseases, Sheba Medical Center, Tel-hashomer, Israel, 7Department of Internal Medicine 'D', Sackler Faculty of Medicine, Tel-Aviv University, Kfar-Saba, Israel

     ACPA induce pathogenic cytokines expression in PBMC of ACPA+-RA patients and inhibition of its effect by Cit-ME a synthetic citrullinated peptide.Smadar Gertel1, Gidi Karmon1, Eszter…
  • Abstract Number: 583 • 2016 ACR/ARHP Annual Meeting

    Associations of Serum Anti-Citrullinated Proteins and Cytokines with Radiographic Scores in African-American Rheumatoid Arthritis Patients

    Dongmei Sun1, William H Robinson2, Xiangqin Cui3, Vincent A. Laufer4, Maria I. Danila5, Richard J. Reynolds6, Chander Raman7, Stephanie Ledbetter8, Alexander Szalai9 and S. Louis Bridges Jr.9, 1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 2Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 3Biostatistics, University of Alabama at Birmingham, Birmingham, AL, 4Division of Clinical Rheumatology and Immunology, University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham, Birmingham, AL, 6Medicine, University of Alabama at Birmingham, Birmingham, AL, 7Medicine/Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 81825 University Blvd., University of Alabama at Birmingham, Birmingham, AL, 9Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Serum anti-citrullinated proteins (ACPA, including anti-CCP antibodies) and rheumatoid factor (RF) are critical diagnostic markers for RA, and are associated with more severe radiographic…
  • Abstract Number: 584 • 2016 ACR/ARHP Annual Meeting

    Glycoprotein VI: A Potential Target for ACPA-Mediated Platelet Activation?

    John Stack1, Anne Madigan2, Laura Helbert1, Niamh Redmond1, Eimear Dunne3, Dermot Kenny3 and Geraldine M. McCarthy2, 1Rheumatology, Mater Misericordiae University Hospital, Dublin, Ireland, 2Rheumatology, Mater Misericordiae University Hospital, Dublin 7, Ireland, 3Molecular and Cellular Therapeutics, RCSI, Dublin 2, Ireland

    Background/Purpose: Arterial thrombosis is a major cause of mortality in  rheumatoid arthritis (RA),especially in anti-citrullinated protein antibody (ACPA)-positive patients Recent studies suggest that platelet activation…
  • Abstract Number: 585 • 2016 ACR/ARHP Annual Meeting

    Disease Associated Anti-Citrullinated Protein Memory B Cells in Rheumatoid Arthritis Persist in DAS Remission

    Adam J. Pelzek1, Caroline Grönwall2, Lelise Getu3, Pamela Rosenthal4, Jeffrey D. Greenberg5, Mandy J. McGeachy6, Larry W. Moreland7 and Gregg J. Silverman8, 1New York University School of Medicine, New York, NY, 2Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 3Department of Medicine, New York University School of Medicine, New York, NY, 4Rheumatology, New York University School of Medicine, New York, NY, 5New York University School of Medicine, Millburn, NJ, 6Medicine, University of Pittsburgh, Pittsburgh, PA, 7Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 8Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY

    Background/Purpose: B cells are central drivers of seropositive RA, and B cells that express anti-citrullinated protein antibodies (ACPA) may arise from past and/or ongoing breaches…
  • Abstract Number: 586 • 2016 ACR/ARHP Annual Meeting

    Association Between ACPA Fine Specificity and High Resolution Computed Tomography Lung Changes in Patients with Early Rheumatoid Arthritis

    Vijay Joshua1, Katerina Chatzidionysiou1, Gudrun Reynisdottir1, Aase Hensvold1, Monika Hansson1, Leonor Nogueira2, Guy Serre2, Johan Grunewald3 and Anca I Catrina1, 1Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 2Unité Différenciation Épidermique et Autoimmunité Rhumatoïde, Unité Mixte de Recherche, INSERM, Toulouse, France, 3Division of Respiratory Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Airways abnormalities that are consistent with inflammation are common in anti-CCP2 positive subjects without inflammatory arthritis. Anti-CCP2 antibodies are associated with high-resolution computed tomography…
  • Abstract Number: 587 • 2016 ACR/ARHP Annual Meeting

    Synovial Immunophenotype and Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiological Prognosis

    Carl Orr1, Aurélie Najm2, Monika Biniecka3, Francis Young1, Ursula Fearon4 and Douglas J. Veale1, 1Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin 4, Ireland, 2Rheumatology, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland, 3St. Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland, 4Trinity College Dublin, Department of Molecular Rheumatology, Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Circulating anti-citrullinated peptide antibodies (ACPA) have been proposed as an important clinical test for stratification of patients presenting with rheumatoid arthritis (RA). ACPA may…
  • Abstract Number: 588 • 2016 ACR/ARHP Annual Meeting

    Radiographic Progression Is Less Significant in Anti-Carbamylated Antibody-Positive Patients with Rheumatoid Arthritis (RA) Who Were Clinically Active and Under the Treatment with Biological Dmards

    Kazuko Shiozawa1, Ken Tsumiyama2 and Shunichi Shiozawa2, 1The Rheumatic Diseases Center, Kohnan Kakogawa Hospital, Kakogawa, Japan, 2Department of Medicine, Rheumatic Diseases Unit, Kyushu University Beppu Hospital, Beppu, Japan

    Background/Purpose: A newly discovered anti-carbamylated protein antibody (anti-CarP) is found prior to disease-onset, associates with the conversion towards arthralgia and with a more severe disease…
  • « Previous Page
  • 1
  • …
  • 1454
  • 1455
  • 1456
  • 1457
  • 1458
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology